A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2011
08/25/2011	WO2011027971A3 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using same
08/25/2011	WO2011005043A3 Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract
08/25/2011	WO2010132757A9 Antibacterial aminoglycoside analogs
08/25/2011	US20110209248 Novel sugar transporters
08/25/2011	US20110209228 Method of treatment using antimicrobial composition
08/25/2011	US20110208673 Antibodies to lymphotoxin-alpha
08/25/2011	US20110207951 7-Iodo Tetracyclines and Related Methods
08/25/2011	US20110207832 Skin disinfectant composition and methods for manufacturing and using
08/25/2011	US20110207816 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
08/25/2011	US20110207800 HIV-Dependent expression constructs and uses therefore
08/25/2011	US20110207799 Compositions for Targeted Delivery of siRNA
08/25/2011	US20110207789 Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
08/25/2011	US20110207787 Antimicrobial compositions
08/25/2011	US20110207768 Pharmaceutical combination of antibacterial and antifungal cream
08/25/2011	US20110207728 Compounds for treating respiratory syncytial virus infections
08/25/2011	US20110207726 Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S
08/25/2011	US20110207725 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
08/25/2011	US20110207720 Quinolin-4-one and 4-oxodihyrdocinnoline derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207704 Novel Oxadiazole Compounds
08/25/2011	US20110207699 Anti-Viral Compounds
08/25/2011	US20110207697 Xanthohumol compositions and methods for treating skin diseases or disorders
08/25/2011	US20110207690 Compositions and methods for treating viral infections
08/25/2011	US20110207688 Heterocyclic antiviral compounds
08/25/2011	US20110207687 Fulvic acid and antibiotic combination
08/25/2011	US20110207684 New low side effect pharmaceutical composition containing isoniazid
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207660 Pharmaceutical formulations of an hcv protease inhibitor in a solid molecular dispersion
08/25/2011	US20110207659 Oligosaccharide compositions and use thereof in the treatment of infection
08/25/2011	US20110207658 High Purity Lipopeptides
08/25/2011	US20110207657 Selectively Targeted Antimicrobial Peptides and the Use Thereof
08/25/2011	US20110207656 MUC1, CASPASE-8, and DED-CONTAINING PROTEINS
08/25/2011	US20110207224 In vivo production of small interfering rnas that mediate gene silencing
08/25/2011	US20110206791 Agent having anti-helicobacter pylori activity
08/25/2011	US20110206786 Acai and Iridoid Based Formulations
08/25/2011	US20110206778 Treatment For Neuropathy, Shingles And Related Disorders
08/25/2011	US20110206765 Non-Typeable Haemophilus Influenzae Vaccines and Their Uses
08/25/2011	US20110206764 Formulations for enhanced bioavailability of orally administered polar agents
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206733 Immunizing Compositions and Methods of Use
08/25/2011	US20110206728 Dna vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
08/25/2011	US20110206727 Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof
08/25/2011	US20110206726 Combination vaccine with acellular pertussis
08/25/2011	US20110206725 Method for purifying protein complexes
08/25/2011	US20110206721 Fermented soy nutritional supplements including mushroom components
08/25/2011	US20110206719 Immunostimulatory oligoribonucleotides
08/25/2011	US20110206718 Anti-fmd vaccine composition and preparation and use thereof
08/25/2011	US20110206717 Non-typhoidal salmonella vaccines
08/25/2011	US20110206715 Molecular differences between species of the m. tuberculosis complex
08/25/2011	US20110206713 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
08/25/2011	US20110206712 Tuberculosis rv2386c protein, compositions and uses thereof
08/25/2011	US20110206711 Method for inducing cytotoxic t-cells, cytotoxic t-cell inducer, and pharmaceutical composition and vaccine employing same
08/25/2011	US20110206710 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
08/25/2011	US20110206708 Method for stimulating a therapeutic immune effect in a patient
08/25/2011	US20110206694 Prevention and treatment of gram negative, flagellated bacterial infections
08/25/2011	US20110206692 Conformers of bacterial adhesins
08/25/2011	US20110206685 Screening assays for inhibitors of a staphylococcus aureus siderophore
08/25/2011	US20110206683 Preservation mixture and use thereof
08/25/2011	US20110206676 Compositions and methods related to staphylococcal bacterium proteins
08/25/2011	US20110206674 Yersinia SPP. Polypeptides and Methods of Use
08/25/2011	US20110206669 Mcp1 fusions
08/25/2011	US20110206650 Probiotic Formulations
08/25/2011	US20110206644 Methods for trans-differentiating cells
08/25/2011	US20110206637 Antiviral agents
08/25/2011	US20110206636 Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus
08/25/2011	US20110206635 Uses of il-12 in hematopoiesis
08/25/2011	US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011	DE102010008982A1 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie A silicon-containing biologically degradable material for anti-inflammatory therapy
08/25/2011	CA2790426A1 Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
08/25/2011	CA2790290A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790289A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790276A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790232A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790228A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	CA2790176A1 Triazolo [4, 5 - b] pyridin derivatives
08/25/2011	CA2790134A1 Pd-1 modulation and uses thereof for modulating hiv replication
08/24/2011	EP2360276A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
08/24/2011	EP2360260A1 BASB006 polynucleotide(s) and polypeptides from Neisseria meningitis
08/24/2011	EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011	EP2360253A1 RNA sequence-specific mediators of RNA interference
08/24/2011	EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
08/24/2011	EP2360251A2 In vivo production of small interfering RNAs that mediate gene silencing
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2360182A1 Therapeutic targeting of escort proteins
08/24/2011	EP2360177A1 Klebsiella antigens
08/24/2011	EP2360169A2 PSMA antibodies
08/24/2011	EP2360168A1 Flavivirus fusion inhibitors
08/24/2011	EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
08/24/2011	EP2360160A1 Intermediates and their use for producing benzoxazine derivative
08/24/2011	EP2359869A2 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same and uses therefor
08/24/2011	EP2359861A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
08/24/2011	EP2359858A1 Nutritional composition comprising indigestible oligosaccharides
08/24/2011	EP2359855A2 Methods of administering anti-TNFalpha antibodies
08/24/2011	EP2359835A1 Viral infection therapeutic drug containing polyalkyleneimine
08/24/2011	EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines
08/24/2011	EP2358740A1 Cyclic peptides and uses thereof
08/24/2011	EP2358736A1 Therapeutic antiviral peptides
08/24/2011	EP2358733A2 Antigens that elicit immune response against flavivirus and methods of using same
08/24/2011	EP2358722A1 Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents
08/24/2011	EP2358682A2 Isoquinolone derivatives as inhibitors of plavivirus replication

1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 1798